Tue Jul 12, 2011, 10:12 AM
|
|
Member
|
|
Join Date: Mar 2010
Location: Maryland
Posts: 453
|
|
|
NIH Trial
http://bethesdatrials.cancer.gov/cli...-0281#eligible
The link above is for a cGvHD study at NIH I've been reading about. Here's an excerpt:
- Trial participants will come to the NIH in Bethesda, MD for a comprehensive, multidisciplinary evaluation lasting 4 days.
- Participants will have blood testing, organ evaluation, and comprehensive consults with multidisciplinary team members.
- Recommendations will be made to participant’s referring physician for GVHD treatment options.
This trial also sounds like a distinct possibility for you, Laura.
__________________
Karen, age 62, dx MDS RAEB-2 1/8/10: pancytopenia WBC 2.7k/Hgb 7.4/Hct 22.1/Plt 19k; complex cytogenetics -3,del(5)(q14q33),-6,+8,+mar,17% blasts. MUD BMT Johns Hopkins 11/30/10. Dx tongue cancer 8/31/12. ok now. blog mausmarrow.com
|